Skip to main navigation
Skip to search
Skip to main content
The University of Brighton Home
Home
Profiles
Research units
Equipment
Projects
Research output
Activities
Student theses
Search by expertise, name or affiliation
Stress and drug resistance in cancer
Renee Flaherty
, Marta Falcinelli
,
Melanie Flint
Centre for Lifelong Health
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Profiles
(1)
Fingerprint
Dive into the research topics of 'Stress and drug resistance in cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Catecholamines
100%
In Cancer
100%
Stress Hormones
100%
Drug Resistance
100%
Psychological Stress Response
100%
Stress Resistance
100%
Chemotherapy
50%
Psychological Stress
50%
Psychological Distress
50%
Immune Function
50%
Cell Survival
50%
Poor Response
50%
Hormone Signaling
50%
Response to Chemotherapy
50%
Adrenaline
50%
Noradrenaline
50%
Multiple Cancer Types
50%
Synthetic Glucocorticoids
50%
Co-medication
50%
Cycle Functions
50%
Exogenous Stress
50%
Immune Therapy
50%
Chemotherapy Efficacy
50%
Mechanistic Evidence
50%
Chemoresistance
50%
Resistance to Chemotherapy
50%
Medicine and Dentistry
Glucocorticoid
100%
Drug Resistance in Cancer
100%
Mental Stress
100%
Catecholamine
66%
Stress Hormone
66%
Malignant Neoplasm
33%
Cell Cycle
33%
Distress Syndrome
33%
Cell Survival
33%
Hormone Signaling
33%
Drug Resistance
33%
Cancer Types
33%
Proteus Syndrome
33%
Epinephrine
33%
Noradrenalin
33%
Immune Function
33%
Immunotherapy
33%
Glucocorticoid Receptor
33%
Chemotherapy
33%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Chemotherapy
100%
Glucocorticoid
100%
Drug Resistance
100%
Catecholamine
66%
Stress Hormone
66%
Distress Syndrome
33%
Noradrenalin
33%
Glucocorticoid Receptor
33%
Epinephrine
33%
Multiple Cancer
33%
Immunotherapy
33%
Immunology and Microbiology
Drug Resistance
100%
Glucocorticoid
100%
Mental Stress
75%
Cell Cycle
25%
Cell Survival
25%
Epinephrine
25%
Immunotherapy
25%